fda statement on compounded semaglutide says 'no clinical need' for weight loss drugs Compounded Semaglutide & Tirzepatide 2025:
Description
In the POUNDS Lost trial, adults with overweight or obesity following calorie-restricted diets lost more weight and were more likely to stay on their plan when they ate more dietary fiber , independent of the overall macronutrient split

References 1 Nevola, 2023

Tired of the hype
One of its primary effects is delayed gastric emptying